The pediatric sepsis biomarker risk model

INTRODUCTION: The intrinsic heterogeneity of clinical septic shock is a major challenge. For clinical trials, individual patient management, and quality improvement efforts, it is unclear which patients are least likely to survive and thus benefit from alternative treatment approaches. A robust risk...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wong, Hector R, Salisbury, Shelia, Xiao, Qiang, Cvijanovich, Natalie Z, Hall, Mark, Allen, Geoffrey L, Thomas, Neal J, Freishtat, Robert J, Anas, Nick, Meyer, Keith, Checchia, Paul A, Lin, Richard, Shanley, Thomas P, Bigham, Michael T, Sen, Anita, Nowak, Jeffrey, Quasney, Michael, Henricksen, Jared W, Chopra, Arun, Banschbach, Sharon, Beckman, Eileen, Harmon, Kelli, Lahni, Patrick, Lindsell, Christopher J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2012
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682273/
https://ncbi.nlm.nih.gov/pubmed/23025259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11652
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller